Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 3/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | TEAD3 | Q99594 | 1/20 | 0.45 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | CASP1 | P29466 | 1/20 | 0.44 |
| ▸ | PAM | P19021 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16345758 | 1.00 | NAAA (0.49) | NAAATSHRSMN1; SMN2LMNATEAD3 | |
| SCHEMBL21421876 | 0.97 | NAAA (0.49) | NAAATSHRSMN1; SMN2LMNATEAD3 | |
| SCHEMBL5038180 | 0.96 | TSHR (0.50) | NAAATSHRSMN1; SMN2LMNATEAD3 | |
| SCHEMBL24675916 | 0.95 | EPHX2 (0.49) | NAAATSHRSMN1; SMN2LMNATEAD3 | |
| SCHEMBL17941306 | 0.95 | L3MBTL1 (0.48) | NAAATSHRSMN1; SMN2LMNATEAD3 | |
| SCHEMBL4963940 | 0.95 | NAAA (0.53) | NAAATSHRSMN1; SMN2LMNATEAD3 | |
| SCHEMBL3543002 | 0.95 | NAAA (0.53) | NAAATSHRSMN1; SMN2LMNATEAD3 | |
| SCHEMBL4966266 | 0.95 | NAAA (0.53) | NAAATSHRSMN1; SMN2LMNATEAD3 | |
| SCHEMBL2469408 | 0.95 | NAAA (0.53) | NAAATSHRSMN1; SMN2LMNATEAD3 | |
| SCHEMBL19698867 | 0.93 | TSHR (0.50) | NAAATSHRSMN1; SMN2LMNATEAD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3337476-A1 | COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF BROMODOMAIN-CONTAINING PROTEINS | Arvinas, Inc. (US) | 2018-06-27 | — | — | EP | disclosed |
| WO-2017030814-A1 | COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF BROMODOMAIN-CONTAINING PROTEINS | Arvinas, Inc. (US) | 2017-02-23 | — | — | WO | disclosed |